These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 9403492

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Decreased cerebrospinal fluid levels of beta-phenylethylamine in patients with Rett syndrome.
    Satoi M, Matsuishi T, Yamada S, Yamashita Y, Ohtaki E, Mori K, Riikonen R, Kato H, Percy AK.
    Ann Neurol; 2000 Jun; 47(6):801-3. PubMed ID: 10852546
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Low CSF HVA levels in the Rett syndrome: a reflection of restricted synapse formation?
    Nielsen JB, Bertelsen A, Lou HC.
    Brain Dev; 1992 May; 14 Suppl():S63-5. PubMed ID: 1378245
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Elevated CSF glutamate in Rett syndrome.
    Hamberger A, Gillberg C, Palm A, Hagberg B.
    Neuropediatrics; 1992 Aug; 23(4):212-3. PubMed ID: 1357572
    [Abstract] [Full Text] [Related]

  • 7. Developmental profile of serum nerve growth factor levels in Rett complex.
    Calamandrei G, Aloe L, Hajek J, Zappella M.
    Ann Ist Super Sanita; 2001 Aug; 37(4):601-5. PubMed ID: 12046231
    [Abstract] [Full Text] [Related]

  • 8. Decreased cerebrospinal fluid levels of beta-endorphin in Japanese patients with Joseph disease.
    Matsuishi T, Sakai T, Nagamitsu S, Komori H, Iwashita H, Kato H.
    Ann Neurol; 1994 Sep; 36(3):441-3. PubMed ID: 8080253
    [Abstract] [Full Text] [Related]

  • 9. Developmental aspects of cerebrospinal fluid levels of beta-phenylethylamine and it's role in pediatric neurological disorders.
    Satoi M.
    Kurume Med J; 1999 Sep; 46(1):17-23. PubMed ID: 10319609
    [Abstract] [Full Text] [Related]

  • 10. [Rett syndrome. A report of fifteen cases].
    Echenne B, Bressot N, Cheminal R, Van Leuwen F, Compagnon P, Azaïs M.
    Ann Pediatr (Paris); 1989 Dec; 36(10):661-8. PubMed ID: 2533856
    [Abstract] [Full Text] [Related]

  • 11. Functional evidence of brain stem immaturity in Rett syndrome.
    Julu PO, Kerr AM, Hansen S, Apartopoulos F, Jamal GA.
    Eur Child Adolesc Psychiatry; 1997 Dec; 6 Suppl 1():47-54. PubMed ID: 9452920
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Evaluation of apoptosis in cerebrospinal fluid of patients with severe head injury.
    Uzan M, Erman H, Tanriverdi T, Sanus GZ, Kafadar A, Uzun H.
    Acta Neurochir (Wien); 2006 Nov; 148(11):1157-64; discussion. PubMed ID: 16964558
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Elevated concentration of hyaluronan in the cerebrospinal fluid is a secondary marker of spinal disorders: hyaluronan in the cerebrospinal fluid in patients with spinal disorders.
    Sakayama K, Kidani T, Sugawara Y, Masuno H, Matsuda Y, Yamamoto H.
    J Spinal Disord Tech; 2006 Jun; 19(4):262-5. PubMed ID: 16778660
    [Abstract] [Full Text] [Related]

  • 20. Substance P immunoreactivity in Rett syndrome.
    Deguchi K, Antalffy BA, Twohill LJ, Chakraborty S, Glaze DG, Armstrong DD.
    Pediatr Neurol; 2000 Apr; 22(4):259-66. PubMed ID: 10788742
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.